Glenmede Trust CO Na Amgen Inc Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Amgen Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 190,395 shares of AMGN stock, worth $50.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

190,395

Previous 232,927 18.26%

Holding current value

$50.4 Million

Previous $72.8 Million 15.71%

% of portfolio

0.3%

Previous 0.37%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $13.2 Million - $14.3 Million	-42,532 Reduced 18.26%	190,395 $61.3 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $16.4 Million - $19.9 Million	-62,372 Reduced 21.12%	232,927 $72.8 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.6 Million - $5.55 Million	-17,113 Reduced 5.48%	295,299 $84 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $10.6 Million - $11.9 Million	-41,396 Reduced 11.7%	312,412 $90 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.19 Million - $1.48 Million	-5,455 Reduced 1.52%	353,808 $95.1 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $31,497 - $37,245	-147 Reduced 0.04%	359,263 $79.8 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $293,978 - $358,310	-1,302 Reduced 0.36%	359,410 $86.9 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $7.27 Million - $9.24 Million	-31,750 Reduced 8.09%	360,712 $94.7 Million
Q3 2022 Nov 16, 2022	BUY	$224.46 - $253.15 $1.59 Million - $1.8 Million	7,103 Added 1.84%	392,462 $88.5 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $6.39 Million - $7.11 Million	-27,704 Reduced 6.71%	385,359 $93.8 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $7.6 Million - $8.4 Million	-34,648 Reduced 7.74%	413,063 $99.9 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $1.92 Million - $2.19 Million	9,638 Added 2.2%	447,711 $101 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $203,142 - $238,005	957 Added 0.22%	438,073 $93.2 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $17.1 Million - $19 Million	-73,313 Reduced 14.36%	437,116 $107 Million
Q1 2021 May 18, 2021	SELL	$221.91 - $258.6 $16.2 Million - $18.8 Million	-72,805 Reduced 12.48%	510,429 $127 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $65,995 - $78,589	305 Added 0.05%	583,234 $134 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $6.4 Million - $7.12 Million	-27,294 Reduced 4.47%	582,929 $148 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $35.7 Million - $43.8 Million	-180,497 Reduced 22.83%	610,223 $144 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $314,277 - $403,955	-1,661 Reduced 0.21%	790,720 $191 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $5.64 Million - $6.75 Million	-32,367 Reduced 3.92%	792,381 $153 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $1.62 Million - $1.9 Million	9,731 Added 1.19%	824,748 $152 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $382,359 - $431,002	-2,114 Reduced 0.26%	815,017 $155 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $14 Million - $16.3 Million	-78,503 Reduced 8.77%	817,131 $159 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $7.94 Million - $8.95 Million	-42,827 Reduced 4.56%	895,634 $186 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $10.3 Million - $11.6 Million	-62,219 Reduced 6.22%	938,461 $173 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $6.18 Million - $6.91 Million	36,618 Added 3.8%	1,000,680 $174 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $161 Million - $184 Million	964,062	964,062 $0

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Amgen Inc Transaction History